The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease

Dopaminergic (DA) cell replacement therapies are a promising experimental treatment for Parkinson’s disease (PD) and a number of different types of DA cell-based therapies have already been trialled in patients. To date, the most successful have been allotransplants of foetal ventral midbrain but ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Qarin, Shamma, Howlett, Sarah K., Jones, Joanne L., Barker, Roger A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2021
Materias:
Immunology & Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438115/
https://www.ncbi.nlm.nih.gov/pubmed/34552761
http://dx.doi.org/10.1042/NS20200083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438115/
https://www.ncbi.nlm.nih.gov/pubmed/34552761
http://dx.doi.org/10.1042/NS20200083

Ejemplares similares